Attention Investors: Note: The depositories (CDSL/NSDL), in coordination with SEBI, have upgraded their investor mobile applications to provide a consolidated view of investors’ holdings in securities markets. CDSL: MyEasiApp | NSDL: Speede App Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.
Experience finance made simple on the new ABCD app!
Scan to Download the App
One stop solution for all stock market enthusiasts
Whatsapp us!! We are Available.
Send HI on 8828800038
For Broking services
Call Toll Free Number :
1800-270-7000
( Mon - Fri: 9AM - 11PM )
( Sat & Sun: 9AM - 09PM )
Call N Trade
Call :
1800-108-9999
( 9AM to 11:30PM /11:55PM )
Acquire & service self-trading online & offline clients. Archive large-scale business success with the entire product range offered by us.
Earn while you refer client. No need to set up your own infrastructure.
Join our referral program, earn rewards when friends and family open accounts & transact. Spread the word, multiply your earnings!
Join the Entrepreneurial Tribe!
Aditya Birla Money Limited
Symbol : UNICHEMLAB | BSE Code : 506690 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN
Market Cap (₹ Cr.)
Turnover (₹ Cr.)
04/04/2026 BSE -1.00(-0.33)Close Price: ₹ 298.45 Volume: 733.00
04/04/2026 BSE 5.70(1.94)Close Price: ₹ 299.45 Volume: 1,646.00
04/04/2026 BSE 9.95(3.51)Close Price: ₹ 293.75 Volume: 6,057.00
04/04/2026 BSE -15.25(-5.10)Close Price: ₹ 283.80 Volume: 6,884.00
04/04/2026 BSE 0.05(0.02)Close Price: ₹ 299.05 Volume: 6,341.00
No Data Available
Net profit of Unichem Laboratories rose 356.85% to Rs 264.29 crore in the quarter ended December 2025 as against Rs 57.85 crore during the previous quarter ended December 2024. Sales declined 2.24% to Rs 521.17 crore in the quarter ended December 2025 as against Rs 533.09 crore during the previous quarter ended December 2024.
Unichem Laboratories consolidated net profit rises 356.85% in the December 2025 quarter
Unichem Laboratories’ Kolhapur API Facility clears USFDA inspection
Unichem Laboratories announces board meeting date
In Cr.
Unichem Laboratories Limited manufactures active pharmaceutical ingredients. The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division. The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh.The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia). The Baddi plant was approved by UK MHRA and MCC (South Africa). The company received ISO 9001:2000 for all their plants and corporate office. Also, they received ISO 14001:2004 certificates for their formulation plants located at Goa, Ghaziabad and Baddi and the corporate office at Mumbai.Unichem Laboratories Limited was incorporated in 1962. The company was formed by Dr. Prakash Amrut Mody to take over a proprietary business set up in 1944 in Mumbai. They made a foreign collaboration with UCB for bulk drugs and set up first formulation plant at Jogeshwari. In the year 1963, they made a tie up with Uni Sankyo Co-Marketing formulations.In the year 1968, the company set up formulations plant Ghaziabad and in the year 1976, they set up a fine chemicals unit at Roha. In the year 1984, the company entered an agreement with Upjohn and set up Unisearch Ltd. Also, they entered into the anti-biotic segment and launched Ampoxin, an Ampicillin & Claxacillin combination during the year.In the year 1987, the company entered the Animal Health Care business. In the year 1996, Unichem Exports Ltd and Unisearch Ltd were merged with the Unichem Laboratories Ltd. In the year 1997, the company set up new corporate office at Mumbai and in May 1997, the company's state-of-the-art formulation plant at Bardez, Goa was successfully commissioned and commercial production was started. In the year 1998, their plan